19 février, 2013by Mario19 February 20131 March 2013Alethia Biothérapeutiques annonce la délivrance d’un brevet japonais concernant des anticoprs monoclonaux ciblant Siglec-15 Alethia 130219 FR Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Name * Email * Website Comment * Save my name, email, and website in this browser for the next time I comment.